UK Stocks: AstraZeneca (AZN) Expands Rare-Disease Portfolio with Amolyt Acquisition

Retrieved on: 2024-03-14 14:06:33

Tags for this article:

Click the tags to see associated articles and topics

UK Stocks: AstraZeneca (AZN) Expands Rare-Disease Portfolio with Amolyt Acquisition. View article details on hiswai:

Excerpt

In top news on UK stocks, AstraZeneca PLC (GB:AZN) announced its acquisition of French biotech company Amolyt Pharma for $1.05 billion in cash.

Article found on: www.tipranks.com